Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Outsourcing

2,800.581
+98.8133.66%
Number of Gainers:8
Number of Losers:- -
Number of Flat:- -
PE:- -
High:2,842.384
Open:2,702.404
Low:2,702.404
Close:2,701.769
Volume:78.06M
Turnover:3.42B
Market Cap:663.86B
Float Cap:278.79B

Loading ...

Core Net Profit Drops Over 40%, Yet TIGERMED (03347) Sees Rising Volume and Price in Secondary Market

Stock News
·
1 hour ago

Biopharmaceutical Stocks Show Broad Gains with CSPC PHARMA Leading with Over 7% Rise

Deep News
·
4 hours ago

CRO Stocks Lead Gains as Biopharma Investment and Cross-Border Deals Rebound

Stock News
·
5 hours ago

Wuxi Biologics (Cayman) Stock Rises 1.5% in Hong Kong

Dow Jones
·
Yesterday

AH Share Premium Rankings for February 9th

Stock News
·
Yesterday

Goldman Sachs: Mainland Healthcare Sector Returns to Hinge on Data and Earnings Visibility This Year, CDMO Firms Favored

Stock News
·
Yesterday

WuXi Biologics Receives EcoVadis Platinum Medal for Third Consecutive Year

Reuters
·
Yesterday

Norges Bank Reduces Stake in Pharmaron by 1.83 Million Shares at HK$20.47 Each

Stock News
·
Feb 06

JPMorgan Reduces Stake in WUXI APPTEC by Approximately 798,119 Shares at HK$109.15 Each

Stock News
·
Feb 06

WuXi Biologics Alliances Deepen Role In Complex Autoimmune And Fusion Drugs

Simply Wall St.
·
Feb 06

Wuxi Biologics (Cayman) Stock Advances 2.6% in Hong Kong

Dow Jones
·
Feb 05

AH Share Premium Rankings as of February 5th

Stock News
·
Feb 05

Wuxi XDC Cayman Inc. verschiebt Versand der Angebotsunterlagen

Reuters
·
Feb 04

TOT BIOPHARM Delays Dispatch of Composite Offer Document

Reuters
·
Feb 04

Assessing WuXi Biologics (SEHK:2269) Valuation After New Autoimmune And Biologics Collaboration Wins

Simply Wall St.
·
Feb 04

ZHITONG A-H SHARE PREMIUM REPORT | FEBRUARY 4

Stock News
·
Feb 04

WuXi Biologics Signs License and Research Service Agreement with Vertex Pharmaceuticals

Reuters
·
Feb 03

WuXi Biologics schließt Lizenz- und Forschungsdienstleistungsvertrag mit Vertex Pharmaceuticals für T-Zell-Engager ab

Reuters
·
Feb 03

WuXi Biologics and Vertex Sign License and Research Service Agreement for T-Cell Engager

THOMSON REUTERS
·
Feb 03

Wuxi Biologics (Cayman) Stock Slides 3.1% in Hong Kong

Dow Jones
·
Feb 02